Trillium Asset Management, LLC Novartis Ag Transaction History

Trillium Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 06, 2019	SELL	$75.32 - $86.15 $192,517 - $220,199	-2,556 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $41,323 - $46,013	-561 Reduced 18.0%	2,556 $219,000
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $15,797 - $18,273	-236 Reduced 7.04%	3,117 $269,000
Q2 2018 Aug 01, 2018	SELL	$64.91 - $73.36 $3.48 Million - $3.93 Million	-53,576 Reduced 94.11%	3,353 $253,000
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $3.74 Million - $4.47 Million	-53,157 Reduced 48.29%	56,929 $4.6 Million
Q4 2017 Feb 01, 2018	SELL	$72.33 - $77.64 $115,077 - $123,525	-1,591 Reduced 1.42%	110,086 $9.24 Million
Q3 2017 Nov 02, 2017	BUY	$74.14 - $77.27 $8.28 Million - $8.63 Million	111,677	111,677 $9.59 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Trillium Asset Management, LLC with notifications on news.